Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Epidemiology and Screening for MelanomaCutaneous Imaging Techniques
Unraveling the Functional Heterogeneity of Human Skin at Single-Cell Resolution
Nevi and Melanoma
Advances in Adjuvant and Neoadjuvant Therapy for Melanoma
Targeted Therapy Innovations for Melanoma
Progress in Immune Checkpoint Inhibitor for Melanoma Therapy
Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity
Melanoma Brain Metastasis: Biology and Therapeutic Advances
Advances in Vaccines for Melanoma
Microbiome and Immunotherapy for Melanoma: Are We Ready for Clinical Application?
High-Risk Non-Melanoma Skin Cancers: Biological and Therapeutic Advances
Cutaneous T-cell Lymphoma
Cutaneous B-Cell Lymphomas
Merkel Cell Carcinoma
Authors
David E. Fisher Edward Wigglesworth Professor & ChairmanDept of Dermatology
Director, Melanoma Program MGH Cancer Center
Director, Cutaneous Biology Research Center
Massachusetts General Hospital
Harvard Medical School.


 
     
   
   
  